Shengsong Huang

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Binding Protein

Cell Proliferation

Endoplasmic Reticulum Stress

Top Venues

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Tao Yang, Yongnan Chi, Xin'an Wang, Chengdang Xu, Xi Chen, Ying Liu, Shengsong Huang, Xuyou Zhu, Haoyang Zhang, Hui Zhuo, Denglong Wu
PRL-mediated STAT5B/ARRB2 pathway promotes the progression of prostate cancer through the activation of MAPK signaling. Cell death & disease 15 (2) (2024)
Tao Yang, Yongnan Chi, Xin'an Wang, Chengdang Xu, Xi Chen, Ying Liu, Shengsong Huang, Xuyou Zhu, Haoyang Zhang, Hui Zhuo, Denglong Wu
PRL-mediated STAT5B/ARRB2 pathway promotes the progression of prostate cancer through the activation of MAPK signaling. Cell death & disease 15 (2) (2024)
Tao Yang, Yongnan Chi, Xin'an Wang, Chengdang Xu, Xi Chen, Ying Liu, Shengsong Huang, Xuyou Zhu, Haoyang Zhang, Hui Zhuo, Denglong Wu
PRL-mediated STAT5B/ARRB2 pathway promotes the progression of prostate cancer through the activation of MAPK signaling. Cell death & disease 15 (2) (2024)
Tao Yang, Yongnan Chi, Xin'an Wang, Chengdang Xu, Xi Chen, Ying Liu, Shengsong Huang, Xuyou Zhu, Haoyang Zhang, Hui Zhuo, Denglong Wu
PRL-mediated STAT5B/ARRB2 pathway promotes the progression of prostate cancer through the activation of MAPK signaling. Cell death & disease 15 (2) (2024)
Qian Zhuang, Shengsong Huang, Zhenfei Li
Prospective role of 3βHSD1 in prostate cancer precision medicine. The Prostate (2023)
Tao Yang, Ying Liu, Shuzhen Chen, Jiale Tian, Xuyou Zhu, Long Zhang, Wei Wang, Yingyi Qin, Jens Richter, Aseem Anand, Chengdang Xu, Yongnan Chi, Chenyang Wang, Cuidong Bian, Denglong Wu, Zhenfei Li, Shengsong Huang
Serum prolactin level as a predictive factor for abiraterone response in patients with metastatic castration-resistant prostate cancer. The Prostate 82 (13) (2022)